Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
Public ClinicalTrials.gov record NCT06308614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, placebo-controlled clinical trial investigated the effect of once daily oral administration of 20 mg estetrol monohydrate tablet for 12 weeks in postmenopausal women who experienced sexual arousal disorder. Specifically, the main aim was to evaluate whether estetrol (E4) is effective in the treatment of female sexual arousal disorder (FSAD) in women after their menopause.
Study identification
- NCT ID
- NCT06308614
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2024
- Primary completion
- Mar 13, 2025
- Completion
- Apr 20, 2025
- Last update posted
- Jul 5, 2026
2024 – 2025
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Estetra Study Site | Mesa | Arizona | 85209 | — |
| Estetra Study Site | Phoenix | Arizona | 85032 | — |
| Estetra Study Site | Tucson | Arizona | 85715 | — |
| Estetra Study Site | Pomona | California | 91767 | — |
| Estetra Study Site | San Diego | California | 92111 | — |
| Estetra Study Site | Jacksonville | Florida | 32256 | — |
| Estetra Study Site | Miami | Florida | 33173 | — |
| Estetra Study Site | New Port Richey | Florida | 34562 | — |
| Estetra Study Site | Ocoee | Florida | 34761 | — |
| Estetra Study Site | Orlando | Florida | 32801 | — |
| Estetra Study Site | West Palm Beach | Florida | 33409 | — |
| Estetra Study Site | Atlanta | Georgia | 30328 | — |
| Estetra Study Site | Chicago | Illinois | 60643 | — |
| Estetra Study Site | Omaha | Nebraska | 68114 | — |
| Estetra Study Site | Las Vegas | Nevada | 89109 | — |
| Estetra Study Site | Albuquerque | New Mexico | 87102 | — |
| Estetra Study Site | Cleveland | Ohio | 44106 | — |
| Estetra Study Site | Englewood | Ohio | 45322 | — |
| Estetra Study Site | Memphis | Tennessee | 38119 | — |
| Estetra Study Site | Houston | Texas | 77061 | — |
| Estetra Study Site | Houston | Texas | 77074 | — |
| Estetra Study Site | Salt Lake City | Utah | 84107 | — |
| Estetra Study Site | Virginia Beach | Virginia | 23456 | — |
| Estetra Study Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06308614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06308614 live on ClinicalTrials.gov.